Patents by Inventor Steven Jay Adelman

Steven Jay Adelman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DRUG DELIVERY AND IMAGING CHEMICAL CONJUGATE, FORMULATIONS AND METHODS OF USE THEREOF
    Publication number: 20210277016
    Abstract: The present invention relates to compounds, and methods of use thereof, capable of entering macrophages. The invention further relates to compounds capable of modulating (for example inhibiting) the activity of the mammalian target of rapamycin (mTor), treating mTor-associated diseases, in particular, but not limited to, related to mTor in macrophages. The invention also relates to compounds capable of imaging mTor in a subject, in particular, but not limited to, mTor in macrophages.
    Type: Application
    Filed: May 26, 2021
    Publication date: September 9, 2021
    Inventors: Steven Jay Adelman, H. Donlon Skerrett, William A. Kinney
  • Drug delivery and imaging chemical conjugate, formulations and methods of use thereof
    Patent number: 11034701
    Abstract: The present invention relates to compounds of Formula 1, and methods of use thereof, capable of entering macrophages. The invention further relates to compounds capable of modulating (for example inhibiting) the activity of the mammalian target of rapamycin (mTor), treating mTor-associated diseases, in particular, but not limited to, related to mTor in macrophages. The invention also relates to compounds capable of imaging mTor in a subject, in particular, but not limited to, mTor in macrophages.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: June 15, 2021
    Assignee: NANOPHAGIX LLC
    Inventors: Steven Jay Adelman, H. Donlon Skerrett, William A. Kinney
  • DRUG DELIVERY AND IMAGING CHEMICAL CONJUGATE, FORMULATIONS AND METHODS OF USE THEREOF
    Publication number: 20180162869
    Abstract: The present invention relates to compounds, and methods of use thereof, capable of entering macrophages. The invention further relates to compounds capable of modulating (for example inhibiting) the activity of the mammalian target of rapamycin (mTor), treating mTor-associated diseases, in particular, but not limited to, related to mTor in macrophages. The invention also relates to compounds capable of imaging mTor in a subject, in particular, but not limited to, mTor in macrophages.
    Type: Application
    Filed: June 15, 2016
    Publication date: June 14, 2018
    Inventors: Steven Jay Adelman, H. Donlon Skerrett, William A. Kinney